Skip to main content
. Author manuscript; available in PMC: 2018 Sep 15.
Published in final edited form as: J Infect Dis. 2017 Sep 15;216(Suppl 4):S539–S547. doi: 10.1093/infdis/jix093

Table 3.

Cross-Reactive HI Antibodies to H3N2v Viruses, by Age Group, in US Human Serum Samples Collected in 2010

Age Group
in 2010, y
Birth Years Subjects, No. HI Titer ≥40 (95% CI), % HI GMT (95% CI)
OH/13/12 IN/6/13 OH/13/12 IN/6/13
6–9 2001–2004 48 17 (6–27) 13 (3–22) 9 (7–11)a 10 (8–13)a
10–19 1991–2000 188 62 (55–69)b 82 (77–88)b 51 (41–64)b 90 (76–108)b
20–29 1981–1990 121 88 (83–94) 90 (85–95) 105 (84–131) 97 (81–117)
30–39 1971–1980 121 74 (66–81)b 55 (47–64)b 49 (41–58)b 32 (27–39)b
40–49 1961–1970 125 34 (25–42) 30 (22–38) 18 (15–22) 18 (15–22)
50–59 1951–1960 99 35 (26–45) 35 (26–45) 19 (15–24) 20 (15–25)
60–69 1941–1950 118 44 (35–53) 48 (39–57) 25 (20–32) 27 (21–35)
70–79 1931–1940 108 52 (42–61) 50 (41–59) 32 (25–41) 28 (22–36)
≥80 1908–1930 79 46 (35–57) 39 (28–50) 23 (17–31) 20 (15–27)
All ages 1908–2004 1007 54 (51–57) 55 (52–58) 33 (31–36) 35 (32–38)

Abbreviations: CI, confidence interval; GMT, geometric mean titer; H3N2v, influenza A(H3N2) variant; HI, hemagglutination-inhibition; IN/6/13, A/Indiana/06/2013; OH/13/12, A/Ohio/13/2012.

a

P = .04 for difference in HI GMT between OH/13/12 and IN/6/13.

b

P < .01 for difference in seroprevalence or HI GMT between OH/13/12 and IN/6/13.